Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
11/2006
11/08/2006CN1283625C Purified LASOFOXIFENE and a method for purification of racemic LASOFOXIFENE by recrystallization
11/08/2006CN1283622C Cyclohexyl (alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
11/08/2006CN1283317C Use of opioid kappa receptor-excited compound in preparing pharmaceuticals for treating septicemia
11/07/2006US7132569 N,N-disubstituted-2,7-dialkyl-8-aryl-4-octeneamides and the intermediates: N,N-disubstituted-5-halo- or azido-2-alkyl-4-pentenamides and 2-alkyl-5-(4-aryl-2-halo- or azido-3-alkylbutylbutyrolactones that may be used to prepare them
11/07/2006US7132568 beta-amino amides; treating degenerative dementias characterized by beta-amyloid deposits in the brain, especially Alzheimer's Disease
11/07/2006US7132546 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
11/07/2006US7132445 Antiinflammatory agents; anticancer agents; analgesics; antiarthritic agents; inflammatory bowel disorders; respiratory system disorders
11/07/2006US7132422 An aromatic-oxy-alkyleneamine derivative, useful for treating neuropathic pain
11/07/2006US7132420 Aspartic protease inhibitors
11/07/2006CA2228613C The n-alkylation of amines
11/07/2006CA2130703C Diacyl-substituted guanidines, a process for their preparation, their use as medicine or diagnostic aid, and medicine containing them
11/02/2006WO2006115456A1 Synthesis of 1-aminopiperidine
11/02/2006WO2006114427A1 Method for producing an amine
11/02/2006WO2006114264A1 Acetylene derivatives
11/02/2006WO2006093823A9 2- [ isoquinolin-s - carbonyl ) amino] -propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis
11/02/2006WO2006069808A3 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments
11/02/2006WO2005041899A3 Orally available sphingosine 1-phosphate receptor agonists and antagonists
11/02/2006US20060247289 Certain chemical entities, compositions, and methods
11/02/2006US20060247264 Modulators of the Glucocorticoid Receptor
11/02/2006US20060247239 Melanin concentrating hormone antagonists
11/02/2006US20060247223 Non-imidazole alkylamines as histamine H3- receptor ligands and their therapeutic applications
11/02/2006US20060246228 Bifunctional photoinitiator such as 2-ethyl-2-hydroxy-1-{4-[4-(2-hydroxy-2-methyl-propionyl)-phenoxy]-phenyl}butan-1-one
11/02/2006EP1717235A2 Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands
11/02/2006EP1717234A1 Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands
11/02/2006EP1717233A1 Histamine H3-receptor ligands and their therapeutic application
11/02/2006EP1716130A1 Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists
11/02/2006EP1716129A1 Piperazine derivatives which exhibit acivity as serotonin and noradrenaline re-upatke inhibitors
11/02/2006EP1214295B1 Hydroxyacetamidobenzenesulphonamide derivatives
11/02/2006EP1127045B1 Triphenylbutene derivatives for the treatment of neurological disorders
11/02/2006CA2605267A1 Acetylene derivatives
11/01/2006CN1856461A Cycloalkylidene compounds as modulators of estrogen receptor
11/01/2006CN1854129A Superhigh purity ionic liquid
11/01/2006CN1854128A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/2006
10/31/2006US7129251 Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use
10/31/2006US7129238 such as (S)-N-(4-Carbamimidoyl-benzyl)-2-methoxy-2-phenyl-acetamide hydrochloride, for inhibiting formation of coagulation factors Xa, IXa and thrombin induced by factor VIIa and tissue factor
10/26/2006WO2006113376A1 2 -aminocarbonyl substituted piperazine or diaza-cyclic compounds as apoptosis protein inhibitor (iap) modulators
10/26/2006WO2006083271A3 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
10/26/2006WO2005099353A3 A novel process for the preparation of linezolid and related compounds
10/26/2006US20060241179 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
10/26/2006US20060241119 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
10/26/2006US20060241113 Polyarylcarboxamides useful as lipid lowering agents
10/26/2006CA2604821A1 2 -aminocarbonyl substituted piperazine or diaza-cyclic compounds as apoptosis protein inhibitor (iap) modulators
10/25/2006EP1713770A1 Selective estrogen receptor modulators
10/25/2006EP1713757A2 Hydroaminomethylation of olefins
10/25/2006EP1401824B1 Aromatic hydroxamic acid derivatives useful as hdac inhibitors
10/25/2006EP1265849B1 Compounds and methods to treat alzheimer's disease
10/25/2006EP1157006B1 Phenyl- and pyridinyl derivatives as neurokinin 1 antagonists
10/25/2006CN1850779A Beta-element nitrogenous derivative, and its preparing method and use
10/25/2006CN1281607C Quaternary ammonium salt compound of piperazine with pain relieving effect
10/25/2006CN1281594C Method I for producing biperiden
10/25/2006CN1281588C Novel intermediate for preparation of pyrazolopyrimidinones
10/25/2006CN1281585C Cyclic diamine compounds having fused-ring groups
10/24/2006US7126012 Has affinity for melatonin receptors and/or selectivity for melatoninergic receptors; antiinflammatory and anticarcinogic agents
10/24/2006US7125997 Differential tumor cytotoxicity compounds and compositions
10/24/2006US7125991 Compounds derived from benzoic acid esters, composition containing said compounds and use thereof
10/24/2006US7125910 Compounds and compositions for delivering active agents
10/24/2006US7125892 Aryl aniline β2 adrenergic receptor agonists
10/24/2006US7125871 Excitatory amino acid receptor modulators
10/24/2006US7125869 Drugs for cosmetics for treatment of cardiovadcular disorders, receptors, immunology or lipid metabolism
10/24/2006CA2363690C Hsv primase inhibitors
10/24/2006CA2300603C New compounds of the benzylaminodiacetamide family, formulations including them, preparation process and uses
10/24/2006CA2261848C Cell adhesion inhibitors
10/24/2006CA2168877C Agent for curing neuronal diseases
10/24/2006CA2158400C Synthesis of 3-[4-(2-aminoethoxy)-benzoyl]-2-aryl-6-hydroxybenzo[b]thiophenes
10/19/2006WO2006108224A1 Antiparasitic compounds
10/19/2006WO2005023182A3 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
10/19/2006US20060235220 Dipeptide nitriles
10/19/2006US20060235073 Diamino-functional chalcones
10/19/2006US20060235049 1-{3-[4-(1-Methyl-pyrrolidin-2-yl)-phenoxy]-propyl}-piperidine, and 1-Benzyl-4-[4-(3-piperidin-1-yl-propoxy)-phenyl]-piperidin-4-ol; histamin receptor antagonist; antidepressant; upper airway allergies, nasal congestion, allergic rhinitis, cognitive dysfunction, schizophrenia, manic disorders
10/19/2006US20060235035 Novel methoxybenzamibe compounds for use in mch receptor related disorders
10/19/2006US20060235027 Inhibitors of cdc25 phosphatases
10/19/2006US20060235024 Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists
10/19/2006US20060234927 Neuroprotective iron chelators and pharmaceutical compositions comprising them
10/19/2006CA2604773A1 Npy antagonists, preparation and use
10/18/2006EP1712242A1 Method of regulating phosphorylation of sr protein and antiviral agents comprising sr protein activity regulator as the active ingredient
10/18/2006EP1711825A2 Conjugated small molecules
10/18/2006EP1711467A2 Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof
10/18/2006EP1711463A2 Amino-substituted tricyclic derivatives and methods of use
10/18/2006EP1711175A1 Diurea derivatives
10/18/2006CN1849308A Thiophenylaminoimidazolines
10/18/2006CN1849117A Entry inhibitors of the HIV virus
10/18/2006CN1280286C Process for the industrial synthesis of thiophenecarboxylicacid, and application thereof
10/18/2006CN1280285C Process for the industrial synthesis of thiophenecarboxylicacid, and application thereof
10/18/2006CN1280267C Sulfonylaminocarboxylic acids
10/18/2006CN1280266C Acylphenylurea derivatives, a process for their preparation and their use as pharmaceuticals
10/18/2006CN1280259C Aryl aniline beta-2 adrenergic receptor agonists
10/18/2006CN1279902C Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
10/17/2006US7122668 Platinum complexes and their use in therapy
10/17/2006US7122580 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc
10/17/2006US7122551 Metalloproteinase inhibitor compounds
10/17/2006US7122543 Substituted benzoic acid derivatives having NF-κB inhibiting action
10/17/2006US7122539 lower gastrointestinal and cardiovascular side effects; use in treatment of respiratory system disorders, as tokolitics and as antiallergics, for eye applications.
10/17/2006US7122535 For treating pain in a warm-blooded animal; enzyme inhibitor on NO-synthase enzymes; STROKE, NEURODEGENERATIVE DISEASES, ISCHEMIC OR HEMORRAGIC CARDIAC OR CEREBRAL INFARCTIONS
10/17/2006US7122529 Administering compound; irradiation with light of selective wavelength; deactivating pathogens in blood
10/17/2006US7122294 generates a free perfluorinated sulfonic acid moiety upon irradiation; photoresists for microlithography and photopolymerization
10/17/2006CA2318527C Inhibitors of .alpha.4 mediated cell adhesion
10/12/2006WO2006106727A1 Benzyloxypropylamine derivative
10/12/2006WO2006106241A1 Piperazine derivatives and use thereof as serotonin reuptake inhibitors or as neurokinin antagonists
10/12/2006US20060229320 Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine
10/12/2006US20060229319 For treatment of allergies; antihistamines